Workflow
RedChip Companies
icon
Search documents
Comprehensive Healthcare Systems Inc. Engages RedChip Companies to Lead Investor Relations Efforts
TMX Newsfile· 2026-01-13 11:30
Core Insights - Comprehensive Healthcare Systems Inc. (CHS) has engaged RedChip Companies to enhance its investor relations and strategic communications efforts, indicating a strategic shift towards greater engagement with the investment community [1][2] - The company is experiencing significant operational and financial milestones, including positive adjusted EBITDA and a growing client base, particularly through its Novus 360 platform [2][3] Company Overview - Comprehensive Healthcare Systems Inc. is a vertically integrated SaaS company focused on healthcare benefits administration, providing high-volume transaction-capable systems [4] - The Novus 360 platform is designed to improve automation, transparency, and cost containment for various clients, including self-funded employers and multi-employer unions across North America [2][4] Financial Engagement - Under the agreement with RedChip, CHS will pay US$7,500 per month and grant 150,000 stock options at a price of C$0.60 per share, with options vesting quarterly over six months [3] - Additionally, CHS has committed to a one-time fee of US$60,000 for a national media and TV ad campaign scheduled for the first quarter of 2026 [3]
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
Globenewswire· 2025-10-28 12:00
Core Insights - ProPhase Labs, Inc. has engaged RedChip Companies to enhance its investor relations efforts as it enters a transformative phase with significant upcoming initiatives [2][3]. Company Developments - The imminent commercialization of the BE-Smart esophageal cancer diagnostic is a key focus for ProPhase, alongside the expansion of the Nebula Genomics platform and the Crown Medical Collections initiative, which aims for over $50 million in near-term recoveries [2]. - ProPhase Labs is positioned as a next-generation biotech, genomics, and consumer products company, emphasizing its commitment to innovation and actionable insights in healthcare [4]. Investor Relations Strategy - RedChip will utilize a comprehensive, multi-channel investor relations platform, including global digital distribution, investor webinars, roadshows, and a television program to communicate ProPhase's story to a broad audience of institutional and retail investors [2]. - Renmark Financial Communications will continue to manage ProPhase's quarterly earnings conference calls and retail investor virtual non-deal roadshows [3].